Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Oct 4;8:327. doi: 10.1186/1752-1947-8-327

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2014 Dias-Santos et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Retinography and fundus fluorescein angiography following therapy with intravitreal bevacizumab. Right eye retinography (top left) reveals no pathologic alterations. Left eye retinography (top right) reveals optic disc and macular edema as well as a dot-blot hemorrhage near the inferotemporal arcade and a mid-peripheral flame-shaped hemorrhage. Right eye fluorescein angiography at 4'00" reveals staining of the optic disc margins (bottom left). Left eye fluorescein angiography at 3'30" reveals a reduction in macular and perivascular exudation in comparison to the previous examination; optic disc edema is also evident (bottom right).